Huiqing Xu

Closed-system manufacturing of CD19 and dual-targeted CD20/19 chimeric antigen receptor T cells using the CliniMACS Prodigy device at an academic medical center.

P. Hari, R. Orentas, D. Schneider, 2017, Cytotherapy.

Long‐term outcomes and predictors of early response, late relapse, and survival for patients treated with bispecific LV20.19 CAR T‐cells

P. Hari, Bryon D Johnson, A. Szabo, 2022, American journal of hematology.

SNHG7 Facilitates Glioblastoma Progression by Functioning as a Molecular Sponge for MicroRNA-449b-5p and Thereby Increasing MYCN Expression

Huiqing Xu, Bo Guan, Yaogang Chen, 2020, Technology in cancer research & treatment.

Bispecific targeting of CD20 and CD19 increases polyfunctionality of chimeric antigen receptor T-cell products in B-cell malignancies.

P. Hari, D. Schneider, N. Shah, 2022, Cytotherapy.

Manufacturing Bispecific LV20.19 CAR T-Cells with IL-7 & IL-15 for a Shorter Duration Improves CAR T-Cell Immunophenotype While Maintaining Target Cell Dose

P. Hari, D. Schneider, N. Shah, 2021, Blood.

Generation of cytotoxic T-cell lines using overlapping pentadecapeptides derived from conserved regions of the adenovirus hexon protein.

D. Margolis, C. Keever-Taylor, F. Zhu, 2010, The Journal of general virology.

CAR-T Cell Production Using the Clinimacs® Prodigy System

P. Hari, R. Orentas, D. Schneider, 2016 .